Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact

Conversations with Giants in Medicine

  • 62 Articles
  • 62 Posts
  • ← Previous
  • 1
  • 2
  • 3
  • …
  • 6
  • 7
  • Next →
A conversation with Griffin Rodgers
Ushma S. Neill
Ushma S. Neill
Published January 4, 2021
Citation Information: J Clin Invest. 2021;131(1):e145540. https://doi.org/10.1172/JCI145540.
View: Text | PDF

A conversation with Griffin Rodgers

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×

A conversation with C. Ronald Kahn
Ushma S. Neill
Ushma S. Neill
Published October 1, 2020
Citation Information: J Clin Invest. 2020;130(10):5029-5030. https://doi.org/10.1172/JCI143687.
View: Text | PDF

A conversation with C. Ronald Kahn

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×

A conversation with Jesse Roth
Ushma S. Neill
Ushma S. Neill
Published July 1, 2020
Citation Information: J Clin Invest. 2020;130(7):3331-3332. https://doi.org/10.1172/JCI138254.
View: Text | PDF

A conversation with Jesse Roth

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×

A conversation with Barbara Kahn
Ushma S. Neill
Ushma S. Neill
Published March 2, 2020
Citation Information: J Clin Invest. 2020;130(3):1053-1054. https://doi.org/10.1172/JCI136339.
View: Text | PDF

A conversation with Barbara Kahn

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×

A conversation with Marc Feldmann, Jacques Miller, and Max Cooper
Marc Feldmann, Ushma S. Neill
Marc Feldmann, Ushma S. Neill
Published January 2, 2020
Citation Information: J Clin Invest. 2020;130(1):1-3. https://doi.org/10.1172/JCI134899.
View: Text | PDF

A conversation with Marc Feldmann, Jacques Miller, and Max Cooper

  • Text
  • PDF
Abstract

Authors

Marc Feldmann, Ushma S. Neill

×

A conversation with Elaine Fuchs
Ushma S. Neill
Ushma S. Neill
Published November 1, 2019
Citation Information: J Clin Invest. 2019;129(11):4551-4552. https://doi.org/10.1172/JCI133402.
View: Text | PDF

A conversation with Elaine Fuchs

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×

A conversation with Lucy Shapiro
Ushma S. Neill
Ushma S. Neill
Published August 1, 2019
Citation Information: J Clin Invest. 2019;129(8):2981-2982. https://doi.org/10.1172/JCI131492.
View: Text | PDF

A conversation with Lucy Shapiro

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×

A conversation with George Church
Ushma S. Neill
Ushma S. Neill
Published April 1, 2019
Citation Information: J Clin Invest. 2019;129(4):1403-1404. https://doi.org/10.1172/JCI128550.
View: Text | PDF

A conversation with George Church

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×

A conversation with Mary-Claire King
Ushma S. Neill
Ushma S. Neill
Published January 2, 2019
Citation Information: J Clin Invest. 2019;129(1):1-3. https://doi.org/10.1172/JCI126050.
View: Text | PDF

A conversation with Mary-Claire King

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×

A conversation with Carla Shatz
Ushma S. Neill
Ushma S. Neill
Published October 1, 2018
Citation Information: J Clin Invest. 2018;128(10):4193-4194. https://doi.org/10.1172/JCI123942.
View: Text | PDF

A conversation with Carla Shatz

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×
  • ← Previous
  • 1
  • 2
  • 3
  • …
  • 6
  • 7
  • Next →
  • ← Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next →
William Paul
William Paul, M.D., is the NIH Distinguished Investigator and Chief of the Laboratory of Immunology within the National Institute of Allergy and Infectious Diseases (NIAID).
Published April 1, 2015
Conversations with Giants in Medicine

James Rothman
For his work on vesicle transport, James Rothman shared the 2013 Nobel Prize in Physiology or Medicine.
Published February 2, 2015
Conversations with Giants in Medicine

David Nathan
David Nathan, professor at Harvard Medical School and President Emeritus of the Dana-Farber Cancer Institute, is a renowned hematologist with contributions to the clinical treatments of β-thalassemia, sickle cell disease, and chronic granulomatous disease.
Published December 2, 2014
Conversations with Giants in Medicine

Peter Agre
Peter Agre was awarded the 2003 Nobel Prize for the discovery of aquaporins. He is currently the director of the Johns Hopkins Malaria Research Institute.
Published November 3, 2014
Conversations with Giants in Medicine

Twenty-six compelling conversations
Since May 2012, the JCI has aired twenty-six interviews with twenty-eight notable scientists for the series Conversations with Giants in Medicine.
Published October 1, 2014
Conversations with Giants in Medicine

Lasker Giants
For the last five years, the JCI has had the privilege of working with the Albert and Mary Lasker Foundation to write profiles on the prizewinners. Coverage of the 2014 laureates will be featured in the October issue. In addition to the news feature...
Published September 2, 2014
Conversations with Giants in Medicine

Napoleone Ferrara
Napoleone Ferrara, of the University of California, San Diego, is best known for isolating and cloning vascular endothelial growth factor (VEGF). He then built the humanized monoclonal antibody against VEGF that led to the blockbuster drugs Avastin ...
Published August 26, 2014
Conversations with Giants in Medicine

Tony Fauci
Tony Fauci is the Director of the National Institute of Allergy and Infectious Diseases within the NIH. His work on HIV is at the forefront of infectious disease research, and he is the leader of the national discussion of infectious disease pandemi...
Published July 1, 2014
Conversations with Giants in Medicine

P. Roy Vagelos
The biochemist P. Roy Vagelos is best known for leading Merck for 20 years, first as President of research and then later as CEO and Chairman of the Board. In his time at Merck, he revolutionized the way the company approached drug discovery, introd...
Published June 2, 2014
Conversations with Giants in Medicine

Bonnie Bassler
Bonnie Bassler of Princeton University and the Howard Hughes Medical Institute has revolutionized the way that we think about microbiology. She elucidated the chemical language that bacteria use to communicate through a process called quorum sensing...
Published April 1, 2014
Conversations with Giants in Medicine
  • ← Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next →
Advertisement
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts